Dogwood Therapeutics Inc. (DWTX)

AI Score

Unlock

5.64

-0.23 (-3.92%)

At close: Apr 24, 2025, 3:59 PM

5.70

1.06%

Pre-market: Apr 25, 2025, 08:35 AM EDT

Dogwood Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-7.54M	-2.3M	-1.07M	-1.31M	-1.14M	-1.27M	-1.48M	-1.56M	-2.09M	-2.59M	-3.67M	-3.96M	-4.19M	-4.11M	-4.28M	-3.06M	-6.42M	-2.66M	-538.38K	-382.55K	-565.73K	-736.33K	-496.13K
Interest Income	n/a	20.49K	19.99K	22.77K	34.95K	39.22K	36.31K	40.42K	n/a	16.61K	4.8K	906.00	n/a	1.51K	1.5K	1.4K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-7.73M	-2.28M	-1.05M	-1.29M	-1.1M	-1.24M	-1.44M	-1.52M	-2.04M	-2.58M	-3.67M	-3.96M	-4.51M	-4.11M	-4.28M	-3.06M	-6.5M	-2.72M	-654.59K	-466.55K	-638.59K	-811.82K	-567.86K
Net Income	-7.73M	-2.28M	-1.05M	-1.29M	-1.1M	-1.24M	-1.44M	-1.52M	-2.04M	-2.58M	-3.67M	-3.96M	-4.51M	-4.11M	-4.28M	-3.06M	-6.5M	-2.72M	-654.59K	-466.55K	-638.59K	-811.82K	-567.86K
Selling & General & Admin	5.23M	1.77M	733.74K	970.38K	839.8K	900.09K	919.37K	1.06M	818K	969.95K	1.27M	1.19M	1.27M	1.15M	1.08M	1.35M	6.39M	2.55M	515.06K	352.01K	270.63K	343.5K	387.49K
Research & Development	2.32M	535.16K	336.08K	343.72K	298.32K	374.2K	557.84K	497.71K	1.27M	1.62M	2.41M	2.77M	2.92M	2.96M	3.21M	1.71M	32.07K	108.09K	23.32K	30.54K	295.1K	392.83K	108.63K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	7.54M	2.3M	1.07M	1.31M	1.14M	1.27M	1.48M	1.56M	2.09M	2.59M	3.67M	3.96M	4.19M	4.11M	4.28M	3.06M	6.42M	2.66M	538.38K	382.55K	565.73K	736.33K	496.13K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	79.58K	104.44K	116.2K	n/a	72.86K	75.49K	71.73K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	7.54M	2.3M	1.07M	1.31M	1.14M	1.27M	1.48M	1.56M	2.09M	2.59M	3.67M	3.96M	4.19M	4.11M	4.28M	3.06M	6.42M	2.66M	538.38K	382.55K	565.73K	736.33K	496.13K
Income Tax Expense	-503	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	1.31M	1.11M	916.03K	770.32K	770.32K	763.75K	736.46K	733.22K	733.22K	368K	333.21K	333.21K	333.21K	333.21K	333.21K	333.04K	208.5K	195.19K	193.3K	193.3K	193.3K	193.3K	193.3K
Shares Outstanding (Diluted)	1.31M	1.11M	916.03K	770.32K	770.32K	763.75K	736.46K	733.22K	733.22K	368K	333.21K	333.21K	333.21K	333.21K	333.21K	333.04K	208.5K	195.19K	193.3K	193.3K	193.3K	193.3K	193.3K
EPS (Basic)	-5.9	-2.05	-1.15	-1.68	-1.43	-1.62	-1.96	-2.07	-2.79	-7	-11.01	-11.89	-13.54	-12.33	-12.85	-9.18	-31.18	-13.96	-3.39	-2.41	-3.3	-4.2	-2.94
EPS (Diluted)	-5.9	-2.05	-1.15	-1.68	-1.43	-1.62	-1.96	-2.07	-2.79	-7	-11.01	-11.89	-13.54	-12.33	-12.85	-9.18	-31.18	-13.96	-3.39	-2.41	-3.3	-4.2	-2.94
EBITDA	-7.57M	-2.3M	-1.07M	-1.31M	-1.14M	-1.27M	-1.48M	-1.56M	-2.09M	-2.59M	-3.67M	-3.96M	-4.19M	-4.11M	-4.28M	-3.06M	-6.42M	-2.66M	-538.38K	-382.55K	-565.73K	-736.33K	-496.13K
EBIT	-7.57M	-2.3M	-1.07M	-1.31M	-1.14M	-1.27M	-1.48M	-1.56M	-2.09M	-2.59M	-3.67M	-3.96M	-4.19M	-4.11M	-4.28M	-3.06M	-6.42M	-2.66M	-538.38K	-382.55K	-565.73K	-736.33K	-496.13K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a